Choreo LLC Takes Position in ICU Medical, Inc. (NASDAQ:ICUI)

Choreo LLC bought a new position in ICU Medical, Inc. (NASDAQ:ICUI) during the second quarter, Holdings Channel reports. The firm bought 2,718 shares of the medical instruments supplier’s stock, valued at approximately $313,000.

Other hedge funds also recently made changes to their positions in the company. Vanguard Group Inc. lifted its position in ICU Medical by 0.5% during the first quarter. Vanguard Group Inc. now owns 2,452,720 shares of the medical instruments supplier’s stock valued at $263,226,000 after purchasing an additional 11,991 shares during the last quarter. Schroder Investment Management Group lifted its holdings in shares of ICU Medical by 35.8% in the 4th quarter. Schroder Investment Management Group now owns 433,852 shares of the medical instruments supplier’s stock valued at $43,272,000 after acquiring an additional 114,344 shares during the last quarter. Silvercrest Asset Management Group LLC grew its position in ICU Medical by 109.4% in the first quarter. Silvercrest Asset Management Group LLC now owns 278,436 shares of the medical instruments supplier’s stock worth $29,882,000 after acquiring an additional 145,485 shares in the last quarter. WCM Investment Management LLC increased its stake in ICU Medical by 5.8% during the first quarter. WCM Investment Management LLC now owns 256,946 shares of the medical instruments supplier’s stock worth $27,575,000 after acquiring an additional 14,138 shares during the last quarter. Finally, Dimensional Fund Advisors LP lifted its stake in shares of ICU Medical by 4.3% in the 4th quarter. Dimensional Fund Advisors LP now owns 220,624 shares of the medical instruments supplier’s stock valued at $22,005,000 after purchasing an additional 9,196 shares during the last quarter. 96.10% of the stock is currently owned by hedge funds and other institutional investors.

ICU Medical Stock Down 1.8 %

Shares of ICUI opened at $176.29 on Wednesday. The firm has a fifty day moving average price of $145.63 and a 200-day moving average price of $119.57. The company has a current ratio of 2.41, a quick ratio of 1.08 and a debt-to-equity ratio of 0.76. The firm has a market capitalization of $4.30 billion, a P/E ratio of -72.03 and a beta of 0.65. ICU Medical, Inc. has a 12-month low of $78.28 and a 12-month high of $181.87.

ICU Medical (NASDAQ:ICUI) last released its quarterly earnings data on Wednesday, August 7th. The medical instruments supplier reported $1.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.00 by $0.56. The company had revenue of $596.50 million during the quarter, compared to analysts’ expectations of $556.64 million. ICU Medical had a negative net margin of 3.07% and a positive return on equity of 5.01%. The firm’s quarterly revenue was up 8.6% on a year-over-year basis. During the same period in the previous year, the company earned $1.58 EPS. Equities research analysts expect that ICU Medical, Inc. will post 3.76 earnings per share for the current year.

Analyst Ratings Changes

ICUI has been the topic of several analyst reports. Needham & Company LLC reissued a “hold” rating on shares of ICU Medical in a research report on Thursday, August 8th. KeyCorp increased their target price on shares of ICU Medical from $136.00 to $147.00 and gave the company an “overweight” rating in a research note on Thursday, August 8th. StockNews.com raised shares of ICU Medical from a “hold” rating to a “buy” rating in a research note on Thursday, September 12th. Finally, Raymond James raised their price objective on shares of ICU Medical from $158.00 to $190.00 and gave the stock an “outperform” rating in a research note on Thursday, September 12th. One investment analyst has rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $149.00.

Insider Buying and Selling

In other ICU Medical news, CEO Vivek Jain sold 12,000 shares of the company’s stock in a transaction on Friday, August 16th. The stock was sold at an average price of $156.04, for a total value of $1,872,480.00. Following the completion of the sale, the chief executive officer now directly owns 104,593 shares in the company, valued at approximately $16,320,691.72. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In other news, CEO Vivek Jain sold 12,000 shares of the company’s stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $156.04, for a total value of $1,872,480.00. Following the completion of the sale, the chief executive officer now owns 104,593 shares of the company’s stock, valued at approximately $16,320,691.72. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Virginia Ruth Sanzone sold 2,050 shares of ICU Medical stock in a transaction that occurred on Thursday, August 8th. The shares were sold at an average price of $144.11, for a total transaction of $295,425.50. Following the transaction, the vice president now directly owns 4,482 shares in the company, valued at $645,901.02. The disclosure for this sale can be found here. Insiders have sold a total of 28,552 shares of company stock valued at $4,537,802 over the last quarter. 6.70% of the stock is owned by corporate insiders.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.